Detalhe da pesquisa
1.
Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study.
Cancer
; 127(9): 1407-1416, 2021 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33434335
2.
Variation in targetable genomic alterations in non-small cell lung cancer by genetic ancestry, sex, smoking history, and histology.
Genome Med
; 14(1): 39, 2022 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35428358